Menu
Close
.svg)
Philadelphia International Airport. Again.
I located a reasonably clean seat near my gate, opened my MacBook, and pulled up tomorrow’s kickoff deck, unsweetened iced tea in hand. Tomorrow’s agenda: a new product launch. New client. High expectations.
Before I left the house -- as I often do before important meetings -- I reached for a book. Not a new release. Not something trendy. Something I trust to sharpen my thinking.
A slim, well-worn copy of ZAG, which has occupied the corner of my desk for years.
It’s the kind of book you can finish on a short flight from Philadelphia to Chicago. It travels easily. It doesn’t demand a linear read. You can open it to almost any page and find a sentence that reframes the marketing problem in front of you.
Nearly twenty years after its publication, it still slices cleanly through the noise -- perhaps even more sharply now than it did then.
Differentiate or die.
For commercial, insights, and analytics leaders in biopharma and medtech navigating today’s AI-saturated, omnichannel ecosystem, ZAG isn’t nostalgic. It’s necessary.
Marty Neumeier wrote ZAG: The Number One Strategy of High-Performance Brands for busy people. It is concise, visual, and refreshingly practical. It invites you to read it. But don’t mistake brevity for simplicity. The core thesis is sharp and enduring:
“When everybody zigs, zag.”
Neumeier argues that the only sustainable competitive advantage is distinctiveness. Not incremental differentiation. Not feature creep. True strategic divergence.
Another line I’ve highlighted:
“If you can’t describe your strategy in 15 words or less, you don’t have one.”
In pharma, biotech, and medtech, complexity isn’t a choice -- it’s part of the terrain. Science is complex. Regulation is complex. Stakeholders are complex. Heck, customer psychology is highly complex. Over time, our strategies tend to mirror that complexity.
Which makes Neumeier’s test a bracing one.
Could your brand team articulate its strategy in 15 words or fewer? Could your sales force? Could the algorithms powering your AI-driven content engine?
If the answer is no, you’re not alone. But you may be optimizing within the same boundaries as everyone else.
We operate in a post-Internet era where omnichannel isn’t aspirational -- it’s now table stakes. AI now generates content, predicts next best action, and personalizes messaging at scale. But here’s the paradox:
The more sophisticated our tools become, the more commoditized our messaging risks becoming.
Algorithms optimize toward patterns. Patterns create sameness. Sameness erodes impact.
ZAG reminds us that strategy precedes execution. Omnichannel orchestration without a sharp, differentiated core merely amplifies noise.
Neumeier writes:
“A brand is not what you say it is. It’s what they say it is.”
In 2026, “they” includes not only physicians and patients, but digital ecosystems, search engines, and AI agents synthesizing information on behalf of decision-makers. "They" includes OpenEvidence. Your brand must stand for something unmistakable -- or it will be flattened into a category cliché.
Before you deploy predictive analytics, pause. What is the zag? Before you scale modular content, ask: does it express a singular, ownable position?
For insights and analytics teams, the philosophy of ZAG offers a powerful filter:
For commercial leaders:
Neumeier outlines a 17-step framework for brand strategy -- simple enough to complete in an afternoon workshop, rigorous enough to provoke executive-level debate. I’ve seen organizations spend millions on transformation initiatives that would have benefited from starting there.
Marty Neumeier is a brand strategist, author, and former design leader who has worked at the junction of business and creativity for decades. He founded Liquid Agency, served as Director of Transformation at Liquid Agency and later at other innovation-focused firms, and has advised companies across industries on brand-led growth.
His bibliography includes:
Across his work runs a consistent theme: clarity beats complexity. Focus beats proliferation. Courage beats conformity.
On this flight, I’ll reread a few dog-eared pages. Not because I’ve forgotten the principles; but because the discipline of revisiting them sharpens thinking.
In an era of machine learning and real-time dashboards, we risk confusing activity with advantage.
ZAG is a reminder that the hardest work in strategy is subtraction. Choosing what not to say. Choosing whom not to serve. Choosing how to be unmistakably different.
If you lead commercial, insights, or analytics in life sciences, I’d encourage you: dust it off. Read it on your next flight.
It just might be the highest ROI two-hour investment you make this quarter.
